the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Official Title Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Principal Investigator DeCara, Jeanne
Brief Summary The purpose of this research study is to see if Atorvastatin(Lipitor) 40 mg by mouth daily decreases the chance of developing heart problems in women receiving adjuvant anthracycline-based chemotherapy for breast cancer.
Gender Female
Ages 30 Years
Enrollment 250
Accepts Healthy Volunteers No
Lead Sponsor Wake Forest University Health SciencesOther
Collaborator National Cancer Institute (NCI)NIH
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name William G Hundley, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Breast Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI